Search research articles
Contact Us
Filters
Showing results (51-60 of 135) with videos related to
Page
of 14
Sort By:
Molecular Pharmacology
|
March 1, 1991
Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells
C E Dusenbury, M A Davis, T S Lawrence, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 15, 1997
A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer
J M Robertson, W D Ensminger, S Walker, et al.
International Journal of Radiation Biology
|
September 1, 1996
Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression
T S Lawrence, M A Davis, H Y Tang, et al.
Radiation Oncology Investigations
|
January 1, 1997
Effect of p53 overexpression on radiation sensitivity of human colon cancer cells
R C Zellars, J D Naida, M A Davis, et al.
Cancer
|
February 1, 1994
Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine
D J Buchsbaum, M B Khazaeli, M A Davis, et al.
The Journal of Cell Biology
|
January 1, 1979
Hormonally induced cell shape changes in cultured rat ovarian granulosa cells
T S Lawrence, R D Ginzberg, N B Gilula, et al.
Neoplasia (New York, N.Y.)
|
August 10, 2000
HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells
M D Axelson, M A Davis, S P Ethier, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Interaction between gemcitabine and mitomycin-C in vitro
T T Aung, M A Davis, W D Ensminger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1992
The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies
J M Robertson, L Marsh, R K Ten Haken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine)
T S Lawrence, E Y Chang, T M Hahn, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 135) with videos related to
Sort By:
Page
of 14
Molecular Pharmacology
|
March 1, 1991
Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells
C E Dusenbury, M A Davis, T S Lawrence, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 15, 1997
A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer
J M Robertson, W D Ensminger, S Walker, et al.
International Journal of Radiation Biology
|
September 1, 1996
Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression
T S Lawrence, M A Davis, H Y Tang, et al.
Radiation Oncology Investigations
|
January 1, 1997
Effect of p53 overexpression on radiation sensitivity of human colon cancer cells
R C Zellars, J D Naida, M A Davis, et al.
Cancer
|
February 1, 1994
Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine
D J Buchsbaum, M B Khazaeli, M A Davis, et al.
The Journal of Cell Biology
|
January 1, 1979
Hormonally induced cell shape changes in cultured rat ovarian granulosa cells
T S Lawrence, R D Ginzberg, N B Gilula, et al.
Neoplasia (New York, N.Y.)
|
August 10, 2000
HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells
M D Axelson, M A Davis, S P Ethier, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Interaction between gemcitabine and mitomycin-C in vitro
T T Aung, M A Davis, W D Ensminger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1992
The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies
J M Robertson, L Marsh, R K Ten Haken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine)
T S Lawrence, E Y Chang, T M Hahn, et al.
Page
of 14